District of Columbia § 48-853.06 Interoperability; information exchange with other prescription drug monitoring programs.

District of Columbia Statutes

§ 48-853.06 — Interoperability; information exchange with other prescription drug monitoring programs.

District of Columbia § 48-853.06

Title 48Foods and Drugs.

Ch. 8GPrescription Drug Monitoring.

This text of District of Columbia § 48-853.06 (Interoperability; information exchange with other prescription drug monitoring programs.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

D.C. Code § 48-853.06 (2026).

Text

(a)The Director may enter into written agreements with other prescription drug monitoring programs, or a third party, approved by the Director, that operates an interstate prescription drug monitoring exchange, for the purpose of interoperability and the mutual exchange of information among prescription drug monitoring programs, and describing the terms and conditions for the sharing of prescription information under this section.

(b)The Director may provide prescription monitoring information pursuant to such agreements, which shall only use the information for the purposes allowed by this chapter.

(c)The Director may request and receive prescription drug monitoring information from other states’ prescription drug monitoring programs and may use the information under the provisions o

Free access — add to your briefcase to read the full text and ask questions with AI

(a) The Director may enter into written agreements with other prescription drug monitoring programs, or a third party, approved by the Director, that operates an interstate prescription drug monitoring exchange, for the purpose of interoperability and the mutual exchange of information among prescription drug monitoring programs, and describing the terms and conditions for the sharing of prescription information under this section.

(b) The Director may provide prescription monitoring information pursuant to such agreements, which shall only use the information for the purposes allowed by this chapter.

(c) The Director may request and receive prescription drug monitoring information from other states’ prescription drug monitoring programs and may use the information under the provisions of this chapter.